Nov 10 (Reuters)-
AFC-HD Ams Life Science Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Aug 31, 2022 Aug 31, 2021 Aug 31, 2023 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 23.00 22.37 24.74 12.19
(+7.6 pct) (+8.9 pct)
Operating 1.01 2.25 1.48 682 mln
(+46.5 pct) (+51.1 pct)
Recurring 1.34 2.16 1.44 662 mln
(+6.9 pct) (+3.0 pct)
Net
Net 735 mln 1.50 800 mln 365 mln
(+8.8 pct) (+18.8 pct)
EPS 52.33 yen 107.12 yen 56.99 yen 26.00 yen
EPS Diluted 52.08 yen 106.30 yen
Ann Div 30.00 yen 27.50 yen 25.00 yen
-Q2 Div 15.00 yen 12.50 yen 12.50 yen
-Q4 Div 15.00 yen 15.00 yen 12.50 yen
NOTE - AFC-HD Ams Life Science Co Ltd.
*Second Net profit row denotes profit attributable to owners ofthe parent
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=2927.T